Shenzhen Hepalink Pharmaceutical Group Co Ltd

002399

Company Profile

  • Business description

    Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business, and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from USA and Europe.

  • Contact

    No. 21 Langshan Road
    Songping Mountain
    Guangdong Province, Nanshan District
    Shenzhen518057
    CHN

    T: +86 75526980200

    https://www.hepalink.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,926

Stocks News & Analysis

stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.
stocks

Our fair value on ASX share falls by half

Downgrading our estimates due to lower growth.
stocks

A 5-Star US stock to buy with a near-5% yield

Undervalued by 23%, this cheap dividend stock is a top pick in its sector.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,148.5045.400.50%
CAC 407,891.4820.800.26%
DAX 4023,788.1948.720.21%
Dow JONES (US)46,247.29299.970.65%
FTSE 1009,349.2864.450.69%
HKSE26,633.87505.671.94%
NASDAQ22,484.0799.370.44%
Nikkei 22545,043.75311.24-0.69%
NZX 50 Index13,132.5620.830.16%
S&P 5006,643.7038.980.59%
S&P/ASX 2008,862.8052.100.59%
SSE Composite Index3,862.5334.430.90%

Market Movers